B+
Bull case
25%
Probability
Target price
$30.00
Analysis reference price unavailable
Analysis 2026-09-02 · RankAlpha Sentiment Codex
INVA
InnovivaANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Durable royalty cash generation, strong IST commercial growth, maintained 2026 sales target, international XACDURO expansion, and continued capital allocation support a constructive medium-term case. [#SEC-8K-2026-08-05]
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +4.4.
What can break
Financial contribution and timing from the Dr. Reddy’s agreement are not quantified.
Momentum
24
Value
71
Sentiment
83
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $24.00 · Bull $30.00 · Bear $17.00Analysis 2026-09-02; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-02 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $35.00
Why
Momentum24 · Δ7d -10.6
Value71 · Δ7d -0.0
Sentiment83 · Δ7d +4.4
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +4.4.
Contradictions & invalidation
- • Financial contribution and timing from the Dr. Reddy’s agreement are not quantified.
- • IST growth and the at-least-$150 million 2026 U.S. sales target require continued commercial execution.
- • The investment portfolio is exposed to fair-value volatility, with Q2 unfavorable changes primarily tied to Armata Pharmaceuticals.
Catalyst clock
2026-08-05
Q2 operating momentum and earnings beat
Lead driver: Sentiment · See AI snapshot
Momentum
24
9% active weight
Current posture
7d trendSoftening
Δ7d
-10.6
Δ21d
+1.5
Value
71
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.3
Sentiment
83
62% active weight
Current posture
7d trendImproving
Δ7d
+4.4
Δ21d
-10.3
Why this grade
Composite grade A. Momentum 23.9 / Value 71.2 / Sentiment 82.6
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-02. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$24.00
Analysis reference price unavailable
Analysis 2026-09-02 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$17.00
Analysis reference price unavailable
Analysis 2026-09-02 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$1.51B
Beta
0.44
Shares Out
72.25M
P/E (TTM)
15.5
P/S (TTM)
3.85
P/FCF (TTM)
7.58
Rev YoY
+18.6%
EPS YoY
-247.0%
Gross Margin
+70.0%
Op Margin
+35.8%
Net Debt
-$297.65M
Current Ratio
16.01
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data